IBIO vs IRD

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 13, 2026

IBIO

36.7
AI Score
VS
IRD Wins

IRD

39.4
AI Score

Investment Advisor Scores

IBIO

37score
Recommendation
AVOID NEW MONEY

IRD

39score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric IBIO IRD Winner
Forward P/E 0 12.0048 Tie
PEG Ratio 0 0 Tie
Revenue Growth -100.0% -63.1% IRD
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 36.7/100 39.4/100 IRD
Profit Margin 0.0% 0.0% Tie
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY AVOID NEW MONEY Tie

Relative Price Performance (Last 90 Days)

IBIO 1M: -6.5% · 3M: -49.5% IRD 1M: -1.7% · 3M: +9.0%

Current Technical Phase

IBIO

Markdown
Sell / avoid

Price below a falling SMA50 (slope -20.4%), weak momentum, RSI 39

RSI (14): 38.9 · Price: $0.73

IRD

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 47

RSI (14): 47.2 · Price: $3.98

Fundamentals Snapshot

Metric IBIO IRD
Market Cap — —
Forward P/E -2.4 -5.3
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 9.8% -0.6%
Gross Margin 1.0% -4.9%
Operating Margin -30.3% -7.8%
EPS -0.27 -1.48
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, IRD is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.